Showing posts with label Anti-epileptic drugs. Show all posts
Showing posts with label Anti-epileptic drugs. Show all posts

Wednesday, 21 May 2025

Psychogenic Nonepileptic Seizures—High Mortality Rate is a ‘Wake-up Call’ | Chapter 11 | Medical Science: Recent Advances and Applications Vol. 4

Patients with epilepsy have an elevated mortality rate compared to the general population, and now studies are showing a comparable death ratio in patients diagnosed with psychogenic nonepileptic seizures. The latter is a top differential diagnosis for epilepsy, and the unexpected mortality rate in these patients underscores the importance of an accurate diagnosis. Experts have called for more studies to elucidate this finding, but the explanation is already available, embedded in the existing data. To illustrate, a review of the diagnostic practice in epilepsy monitoring units, of the studies examining mortality in PNES and epilepsy patients, and of the general clinical literature on the two populations was conducted. The analysis reveals that the scalp EEG test result, which distinguishes a psychogenic from an epileptic seizure, is highly fallible; that the clinical profiles of the PNES and epilepsy patient populations are virtually identical; and that both are dying of natural and non-natural causes including sudden unexpected death associated with confirmed or suspected seizure activity. The recent data showing a similar mortality rate simply constitutes more confirmatory evidence that the PNES population consists largely of patients with drug-resistant scalp EEG-negative epileptic seizures. To reduce the morbidity and mortality in these patients, they must be given access to treatments for epilepsy.

 

Author (s) Details

Catherine A. Carlson
Minnesota Judicial Branch, Psychological Services Division, Minneapolis, MN 55487, USA.

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v4/5130

 

Friday, 16 June 2023

Analysis of Cost Variance for Anti-Epileptic Medications from Various Manufacturers in the Indian Pharmaceutical Market | Chapter 4 | Novel Aspects on Pharmaceutical Research Vol. 3

 Drug-persuaded myopathy, a disease at which point taking certain drugs can diminish or destroy powers. Although the prevalence concerning this illness brought on for one drug Telmisartan is unknown, it is popular that 150 different pharmaceuticals, containing statins, corticosteroids, anti-retroviral situations, and immunosuppressants, have been linked to myotoxicity. Guidelines warn therapeutic drug listening, which is usually evaluating the levels of the medication in a patient's distribution, to manage the risk of drug-inferred myopathy linked to Telmisartan. Additionally, it concede possibility be highlighted that using Telmisartan is indulged with a slightest rise in blood creatinine, a synthetic produced by influence tissue, of up to 20–30%. However, it is considered to stop the therapy if the antitoxin creatinine level rises by more than 30%. The case defined in the paragraph involves a patient the one was thought to have knowledgeable an adverse drug reaction (ADR) to the hypertension treatment Telmisartan. The ADR with Telmisartan was driven to be "Probable" later conducting a origin analysis utilising Naranjo's treasure and the WHO-UMC Scale. As a result, the drug was removed and replaced accompanying Enalapril. The new drug helped the patient's condition, and after lab experiment revealed that the patient's levels of uric acid and creatinine were both inside normal ranges. The division focuses on how critical it is to closely monitor pharmacological medicine, especially when it includes prolonged use, so that protect victims. Myotoxicity, a rare but serious antagonistic drug reaction, was the particular ADR connected to the drug Telmisartan in this place instance. To prevent additional toxicity, Telmisartan was not administered to the patient repeated.

Author(s) Details:

Hansraj Kumar,
Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, Jharkhand, India.

Please see the link here: https://stm.bookpi.org/NAPR-V3/article/view/10879